Aedifica stock trades 33.44 percent below analyst target

Published on 10/07/2026 at 14:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aedifica stock costs EUR 62.05 on October 7, 2026, versus EUR 82.80. Half-year 2026 sales reached EUR 292.31 million, with a EUR 4.20 proposed dividend.

Syensqo S.A. (BE0003851681) - Börsen-Editorial — Syensqo S.A. (BE0003851681) im Börsen-Editorial-Stil mit Trading-Floor, Kurscharts und professionellen Analysten im Fokus, Illustration mit AI erstellt.

Aedifica stock (ISIN BE0003851681) was trading at EUR 62.05 at Lang & Schwarz on October 7, 2026 at 2:43 p.m. CEST. The price stood 33.44 percent below the EUR 82.80 average 12-month analyst target listed by Investing.com.

Analyst target leaves a wide gap

The EUR 82.80 average target comes from 10 analyst views, including eight Buy ratings and two Hold ratings, according to Investing.com. Barclays was listed with a Buy rating and a EUR 76.00 target dated September 8, 2026, while Kepler Cheuvreux carried a Buy rating and a EUR 82.00 target dated September 3, 2026.

For investors, the target gap is more meaningful than the headline price alone: the average target is EUR 20.75 above the Lang & Schwarz quote. The comparison uses the same euro currency, while the analyst page separately shows a 52-week range of EUR 59.50 to EUR 80.05.

Half-year results support income case

Aedifica reported half-year 2026 sales of EUR 292.31 million, net income of EUR 509.57 million and basic earnings per share of EUR 7.28, as summarized by Simply Wall St on September 14, 2026. The figures give the valuation discussion an operating anchor beyond the share-price gap.

The same report said Aedifica proposed a gross dividend of EUR 4.20 per share for fiscal 2026, a 5.00 percent increase. That payout proposal creates a clear income measure, but the company remains exposed to refinancing costs and tenant performance as a healthcare real estate owner.

Next report arrives November 18

Aedifica's investor calendar schedules an interim statement for November 18, 2026 at 5:40 p.m. CET, according to the company's investor page. That date gives the market a defined checkpoint for rental income, portfolio values and capital allocation after the half-year figures.

Healthcare property remains central

Aedifica owns and manages healthcare real estate across Europe, with a particular focus on facilities for elderly care. The company is listed on Euronext Brussels under ticker AED.BR and is a BEL 20 component, according to Global Banking & Finance Review and Euronext. The structure links the valuation debate to recurring care-related rental demand rather than to a general property cycle.

Stock remains below analyst target

Aedifica was trading at EUR 62.05 at Lang & Schwarz on October 7, 2026 at 2:43 p.m. CEST. The reference price was EUR 20.75 below the EUR 82.80 average analyst target.

The further course of trading is shown by the continuously updated real-time quote of Aedifica stock.